You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic myelogenous leukemia in accelerated phase or blast-crisis

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Overland Park (TP-05 (lotilaner oral capsules), Placebo)

Completed
  • Healthy
  • TP-05 (lotilaner oral capsules)
  • Placebo
  • Overland Park, Kansas
    Altasciences
Aug 1, 2022

Melanoma Trial in France, Germany, United States (Talimogene laherparepvec, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Tucson, Arizona
  • +39 more
Mar 9, 2022

Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in China, Taiwan (TJ202, Lenalidomide and Dexamethasone,

Active, not recruiting
  • Multiple Myeloma in Relapse
  • Refractory Multiple Myeloma
  • TJ202, Lenalidomide and Dexamethasone
  • Lenalidomide and Dexamethasone
  • Beijing, Beijing, China
  • +40 more
Oct 17, 2022

Refractory Aplastic Anemia Trial in Tianjin (Decitabine)

Terminated
  • Refractory Aplastic Anemia
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Aug 25, 2022

Sickle Cell Disease Trial in Birmingham, Palo Alto, Saint Louis (GPH101 Drug Product)

Active, not recruiting
  • Sickle Cell Disease
  • GPH101 Drug Product
  • Birmingham, Alabama
  • +2 more
Jan 5, 2023

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)

Not yet recruiting
  • HPV Infection
  • HPV-Related Cervical Carcinoma
  • FluBHPVE6E7
  • Placebo
  • (no location specified)
Apr 24, 2023

First-line Treatment of Non-clear Renal Cell Carcinoma Trial (Fruquintinib combined with Serplulimab)

Not yet recruiting
  • First-line Treatment of Non-clear Renal Cell Carcinoma
  • Fruquintinib combined with Serplulimab
  • (no location specified)
Apr 16, 2023

Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

Recruiting
  • Salivary Gland Cancer
  • Nagoya, Aichi, Japan
  • +11 more
Jan 21, 2023

Liver Transplantation Trial in United States (Normothermic Machine Perfusion (NMP))

Active, not recruiting
  • Liver Transplantation
  • Normothermic Machine Perfusion (NMP)
  • Aurora, Colorado
  • +6 more
Aug 13, 2022

Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Metastatic Cancer
  • (no location specified)
Aug 12, 2022

Hematologic Malignancies Trial in Australia, United States (APG-2575)

Recruiting
  • Hematologic Malignancies
  • Jacksonville, Florida
  • +4 more
Aug 12, 2022

Advanced Cancer Trial in Chengdu, Hangzhou (TQB2223 injection+ Penpulimab Injection)

Recruiting
  • Advanced Cancer
  • TQB2223 injection+ Penpulimab Injection
  • Chengdu, Sichuan, China
  • +1 more
Jun 7, 2023

Depression Trial in Berlin (Music-based couple therapy.)

Completed
  • Depression
  • Music-based couple therapy.
  • Berlin, Germany
    Humboldt-Universität zu Berlin
Apr 12, 2022

SARS-CoV-2 Trial in Changsha, Xiangtan (SARS-CoV-2 (LVRNA009) 50µg group, SARS-CoV-2 (LVRNA009) 100µg group, Placebo)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 (LVRNA009) 50μg group
  • +2 more
  • Changsha, Hunan, China
  • +1 more
Jul 19, 2022

Hepatitis C Virus Infection Trial in Worldwide (SOF/VEL)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Los Angeles, California
  • +26 more
Oct 5, 2020

Multiple Myeloma, Relapse Multiple Myeloma Trial in Bethesda, Madison (Descartes-25)

Recruiting
  • Multiple Myeloma
  • Relapse Multiple Myeloma
  • Shreveport, Louisiana
  • +3 more
Nov 4, 2022

Hepatocellular Carcinoma, Cancer of Liver Trial (PXS-5505 and Atezolizumab and Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Cancer of Liver
  • PXS-5505 and Atezolizumab and Bevacizumab
  • Rochester, New York
    University of Rochester
Nov 3, 2022

PTSD Trial in Worldwide (MDMA)

Recruiting
  • PTSD
  • Klecany, Středočeský Kraj, Czechia
  • +8 more
Aug 25, 2022

Stroke Trial in Brussel (Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) implemented at the patient

Not yet recruiting
  • Stroke
  • Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) implemented at the patient home
  • +3 more
  • Brussel, Belgium
    MSL-IN lab, IoNS, UCLouvain
Feb 13, 2023

Multiple Chronic Conditions, Chronic Disease, Disease Progression Trial in San Francisco

Active, not recruiting
  • Multiple Chronic Conditions
  • +4 more
    • San Francisco, California
      Virta Health
    Apr 25, 2022

    Multiple Sclerosis, NMO Spectrum Disorder Trial in Hangzhou (LP-168 tablet, LP-168 Placebo tablet)

    Recruiting
    • Multiple Sclerosis
    • NMO Spectrum Disorder
    • LP-168 tablet
    • LP-168 Placebo tablet
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital Zhejiang University School of Med
    Jun 26, 2022

    Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Frankfurt, Hannover, Jena (Delcath Hepatic Delivery System,

    Terminated
    • Hepatocellular Carcinoma
    • Intrahepatic Cholangiocarcinoma
    • Frankfurt, Germany
    • +2 more
    Oct 13, 2022

    Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Phoenix, Arizona
      Retinal Research Institute, LLC
    Jun 4, 2023

    Healthy Trial in Charleston (Transcranial alternating current stimulation (tACS) combined with behavioral intervention, Inactive

    Recruiting
    • Healthy
    • Transcranial alternating current stimulation (tACS) combined with behavioral intervention
    • Inactive (sham) stimulation combined with behavioral intervention
    • Charleston, South Carolina
      Medical University of South Carolina
    Jul 7, 2023